Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072839
Status:
COMPLETED
Last Update Posted:
2021-05-25
First Post:
2003-11-11
Brief Title:
Safety and Efficacy of ALX-0600 in Subjects With Active Crohns Disease
Sponsor:
Shire
Organization:
Takeda
Study Overview
Official Title:
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohns Disease
Status:
COMPLETED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine whether an investigational compound ALX-0600 is safe and effective in treating Crohns Disease
Detailed Description:
The study is twelve weeks in duration and there are eight weeks of once-daily injections into your abdomen or thigh There are a total of six visits
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None